Johnson & Johnson Single-Shot Vaccine Safe in Trials: Report

The Phase 1-2 trial of the Johnson & Johnson vaccine candidate produces an immune response in patients who receive the shot.

Last News

'Cobra Kai' Star Ralph Macchio Shares His Best Marriage Advice

This New Food Brand Is Making a Healthy Instant Ramen

‘You are violating my rights!’ Florida woman jailed — again — for refusing to wear a mask

2023 Toyota GR Corolla hot hatch could land with 260 hp and all-wheel drive

Kyra Sedgwick Reveals Which Red Carpet Look with Husband Kevin Bacon 'Went Wrong'

Cardinals, Flaherty still without deal, swap arb figures